Transcriptomic analysis reveals that IL-1R8/Sigirr is a novel macrophage migration regulator and suppresses macrophage proliferation through p38 MAPK signaling pathway - 11/02/20
, Chuanbin Mao d, ⁎
, Rongfei Wei b, c, e, ⁎ 
| pagine | 8 |
| Iconografia | 6 |
| Video | 0 |
| Altro | 0 |
Highlights |
• | We identified pathways correlated with IL-1R8 expression in mouse splenocytes by gene expression microarrays. |
• | Cell migration-related genes downregulated in Il1r8−/− splenocytes were identified. |
• | IL-1R8-depleted RAW264.7 cells or Il1r8−/− BMDMs exhibited impaired cell migration. |
• | IL-1R8 is a new positive regulator for macrophage migration. |
• | IL-1R8 suppresses macrophage proliferation in a p38 MAPK-dependent manner. |
Abstract |
IL-1R8, also known as the Single immunoglobin interleukin-1 (IL-1)-related receptor (Sigirr), has been demonstrated as a negative regulator of IL-1R and Toll-like receptor (TLR) downstream signaling pathways and inflammation. However, the role of IL-1R8 in macrophage migration and proliferation remains unknown. Here we investigated transcriptome profiles of WT and Il1r8-deficient splenocytes and found that innate immunity and cell migration related pathways were significantly correlated with IL-1R8 expression. Cell migration-related genes were downregulated in Il1r8−/− splenocytes or IL-1R8-depleted RAW264.7 cells. Further experiments revealed that IL-1R8-depleted RAW264.7 cells or Il1r8−/− BMDMs exhibited impaired cell migration. Moreover, we found that IL-1R8 suppresses macrophage proliferation through p38 MAPK signaling pathway. Therefore, our study suggests that IL-1R8 is a new positive regulator for macrophage migration and suppresses macrophage proliferation.
Il testo completo di questo articolo è disponibile in PDF.Keywords : IL-1R8, Transcriptomic analysis, Macrophage, Cell migration, Proliferation
Mappa
Vol 124
Articolo 109846- aprile 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
